Operaciones Faes Farma, S.A. - FAE CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.09 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.019974% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.002248% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | EUR | ||||||||
Margen | 20% | ||||||||
Mercado de valores | Spain | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Faes Farma SA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Cierre previo* | 3.29 |
Abrir* | 3.26 |
Cambio de 1 año* | -17.88% |
Rango del día* | 3.26 - 3.35 |
Rango de 52 semanas | 3.01-4.14 |
Volumen medio (10 días) | 330.18K |
Volumen medio (3 meses) | 7.54M |
Capitalización de mercado | 1.08B |
Ratio P/E | 11.85 |
Acciones en circulación | 316.69M |
Ingresos | 438.75M |
EPS | 0.28 |
Dividendo (Rendimiento %) | 4.57584 |
Beta | 0.60 |
Próxima fecha de resultados | Jul 27, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 3.29 | 0.06 | 1.86% | 3.23 | 3.36 | 3.23 |
Jun 1, 2023 | 3.29 | 0.05 | 1.54% | 3.24 | 3.30 | 3.24 |
May 31, 2023 | 3.28 | 0.03 | 0.92% | 3.25 | 3.32 | 3.25 |
May 30, 2023 | 3.32 | -0.02 | -0.60% | 3.34 | 3.35 | 3.29 |
May 29, 2023 | 3.31 | -0.05 | -1.49% | 3.36 | 3.38 | 3.30 |
May 26, 2023 | 3.36 | 0.02 | 0.60% | 3.34 | 3.37 | 3.32 |
May 25, 2023 | 3.37 | 0.01 | 0.30% | 3.36 | 3.40 | 3.34 |
May 24, 2023 | 3.38 | 0.02 | 0.60% | 3.36 | 3.39 | 3.33 |
May 23, 2023 | 3.40 | 0.05 | 1.49% | 3.35 | 3.42 | 3.32 |
May 22, 2023 | 3.40 | 0.07 | 2.10% | 3.33 | 3.40 | 3.33 |
May 19, 2023 | 3.40 | 0.01 | 0.29% | 3.39 | 3.41 | 3.34 |
May 18, 2023 | 3.40 | 0.03 | 0.89% | 3.37 | 3.42 | 3.36 |
May 17, 2023 | 3.33 | -0.04 | -1.19% | 3.37 | 3.39 | 3.33 |
May 16, 2023 | 3.36 | 0.01 | 0.30% | 3.35 | 3.39 | 3.31 |
May 15, 2023 | 3.36 | 0.00 | 0.00% | 3.36 | 3.38 | 3.36 |
May 12, 2023 | 3.36 | 0.05 | 1.51% | 3.31 | 3.37 | 3.28 |
May 11, 2023 | 3.33 | -0.02 | -0.60% | 3.35 | 3.39 | 3.32 |
May 10, 2023 | 3.36 | -0.02 | -0.59% | 3.38 | 3.38 | 3.33 |
May 9, 2023 | 3.40 | 0.06 | 1.80% | 3.34 | 3.40 | 3.33 |
May 8, 2023 | 3.36 | 0.09 | 2.75% | 3.27 | 3.38 | 3.27 |
Faes Farma, S.A. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Wednesday, June 14, 2023 | ||
Hora (UTC) (UTC) 11:00 | País ES
| Evento Faes Farma SA Annual Shareholders Meeting Faes Farma SA Annual Shareholders MeetingForecast -Previous - |
Thursday, June 22, 2023 | ||
Hora (UTC) (UTC) 10:59 | País ES
| Evento Faes Farma SA Annual Shareholders Meeting Faes Farma SA Annual Shareholders MeetingForecast -Previous - |
Thursday, July 27, 2023 | ||
Hora (UTC) (UTC) 10:59 | País ES
| Evento Half Year 2023 Faes Farma SA Earnings Release Half Year 2023 Faes Farma SA Earnings ReleaseForecast -Previous - |
Wednesday, October 25, 2023 | ||
Hora (UTC) (UTC) 10:59 | País ES
| Evento Q3 2023 Faes Farma SA Earnings Release Q3 2023 Faes Farma SA Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 438.754 | 398.557 | 380.24 | 357.398 | 324.312 |
Ingresos | 438.754 | 398.557 | 380.24 | 357.398 | 324.312 |
Coste de los ingresos, total | 156.739 | 146.16 | 140.403 | 129.988 | 120.178 |
Beneficio bruto | 282.015 | 252.397 | 239.837 | 227.41 | 204.134 |
Gastos totales de explotación | 337.271 | 305.302 | 293.469 | 282.539 | 262.339 |
Gastos de venta/general/administración Gastos, total | 117.013 | 109.108 | 107.108 | 105.25 | 95.904 |
Investigación y desarrollo | 3.716 | 3.888 | 3.246 | 4.175 | 2.821 |
Depreciation / Amortization | 19.271 | 17.257 | 14.826 | 12.533 | 10.254 |
Gastos (ingresos) extraordinarios | 0.439 | 3.858 | 5.54 | 4.118 | 0.035 |
Other Operating Expenses, Total | 40.093 | 25.031 | 22.346 | 26.475 | 33.147 |
Ingresos de explotación | 101.483 | 93.255 | 86.771 | 74.859 | 61.973 |
Ingresos por intereses (gastos), netos No operativos | -0.315 | -0.312 | -2.045 | -0.743 | -0.318 |
Otros, netos | 0.253 | 0.023 | 0.156 | 0.059 | 0.076 |
Ingresos netos antes de impuestos | 101.421 | 92.966 | 84.882 | 74.175 | 61.731 |
Ingresos netos después de impuestos | 89.502 | 82.446 | 73.376 | 64.026 | 51.8 |
Beneficio neto antes de partidas extra. Elementos | 89.55 | 82.39 | 72.549 | 63.962 | 51.592 |
Ingresos netos | 89.55 | 82.39 | 72.549 | 63.962 | 51.592 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 89.55 | 82.39 | 72.549 | 63.962 | 51.592 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 89.55 | 82.39 | 72.549 | 63.962 | 51.592 |
Beneficio neto diluido | 89.55 | 82.39 | 72.549 | 63.962 | 51.592 |
Promedio ponderado de acciones diluidas | 316.631 | 329.674 | 316.325 | 316.795 | 317.846 |
BPA diluido sin partidas extraordinarias | 0.28282 | 0.24991 | 0.22935 | 0.2019 | 0.16232 |
Dividends per Share - Common Stock Primary Issue | 0.03382 | 0.0508 | 0.01896 | ||
BPA normalizado diluido | 0.28404 | 0.26029 | 0.24449 | 0.21312 | 0.16241 |
Intereses menores | 0.048 | -0.056 | -0.827 | -0.064 | -0.208 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Ingresos totales | 105.444 | 102.31 | 114.79 | 116.21 | 103.452 |
Ingresos | 105.444 | 102.31 | 114.79 | 116.21 | 103.452 |
Coste de los ingresos, total | 37.368 | 38.892 | 38.896 | 41.69 | 40.663 |
Beneficio bruto | 68.076 | 63.418 | 75.894 | 74.52 | 62.789 |
Gastos totales de explotación | 90.21 | 77.92 | 84.535 | 84.606 | 92.771 |
Gastos de venta/general/administración Gastos, total | 25.154 | 19.133 | 24.128 | 22.786 | 23.795 |
Depreciation / Amortization | 4.884 | 5.292 | 4.78 | 4.315 | 4.754 |
Other Operating Expenses, Total | 22.365 | 14.603 | 16.731 | 15.815 | 19.701 |
Ingresos de explotación | 15.234 | 24.39 | 30.255 | 31.604 | 10.681 |
Ingresos por intereses (gastos), netos No operativos | -0.238 | 0.187 | 0.182 | -0.219 | |
Ingresos netos antes de impuestos | 14.996 | 24.197 | 30.442 | 31.786 | 10.462 |
Ingresos netos después de impuestos | 15.468 | 20.979 | 26.284 | 26.771 | 11.814 |
Beneficio neto antes de partidas extra. Elementos | 15.557 | 21.086 | 26.288 | 26.619 | 11.73 |
Ingresos netos | 15.557 | 21.086 | 26.288 | 26.619 | 11.73 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 15.557 | 21.086 | 26.288 | 26.619 | 11.73 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 15.557 | 21.086 | 26.288 | 26.619 | 11.73 |
Beneficio neto diluido | 15.557 | 21.086 | 26.288 | 26.619 | 11.73 |
Promedio ponderado de acciones diluidas | 316.394 | 317.765 | 312.457 | 316.962 | 355.982 |
BPA diluido sin partidas extraordinarias | 0.04917 | 0.06636 | 0.08413 | 0.08398 | 0.03295 |
Dividends per Share - Common Stock Primary Issue | 0 | 0.03575 | 0 | 0.035 | |
BPA normalizado diluido | 0.05007 | 0.06636 | 0.08413 | 0.08398 | 0.04 |
Intereses menores | 0.089 | 0.107 | 0.004 | -0.152 | -0.084 |
Gastos (ingresos) extraordinarios | 0.439 | 3.858 | |||
Total Adjustments to Net Income | 0 | ||||
Otros, netos | -0.193 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 313.211 | 293.711 | 290.007 | 222.989 | 217.581 |
Efectivo e inversiones a corto plazo | 84.1 | 73.408 | 93.136 | 54.183 | 76.409 |
Efectivo y Equivalentes | 66.411 | 70.254 | 91.21 | 52.853 | 76.038 |
Inversiones a corto plazo | 17.689 | 3.154 | 1.926 | 1.33 | 0.371 |
Total deudores, neto | 113.593 | 112.492 | 104.905 | 96.813 | 81.537 |
Accounts Receivable - Trade, Net | 101.168 | 101.489 | 98.773 | 90.476 | 77.061 |
Total Inventory | 115 | 107.451 | 91.591 | 71.454 | 59.305 |
Prepaid Expenses | 0.518 | 0.36 | 0.375 | 0.539 | 0.33 |
Total Assets | 725.67 | 645.114 | 581.517 | 493.673 | 471.204 |
Property/Plant/Equipment, Total - Net | 205.804 | 139.628 | 95.245 | 83.932 | 67.057 |
Property/Plant/Equipment, Total - Gross | 288.209 | 216.569 | 167.531 | 150.913 | 129.674 |
Accumulated Depreciation, Total | -82.405 | -76.941 | -72.286 | -66.981 | -62.617 |
Goodwill, Net | 51.776 | 53.33 | 52.643 | 61.503 | 53.941 |
Intangibles, Net | 126.911 | 129.431 | 112.88 | 106.99 | 111.737 |
Long Term Investments | 6.682 | 2.54 | 1.888 | 2.01 | 1.881 |
Other Long Term Assets, Total | 21.286 | 26.474 | 28.854 | 16.249 | 19.007 |
Total Current Liabilities | 94.428 | 79.307 | 84.685 | 72.279 | 103.751 |
Accounts Payable | 36.594 | 37.925 | 41.973 | 36.185 | 35.644 |
Accrued Expenses | 12.002 | 11.97 | 13.349 | 11.721 | 10.918 |
Notes Payable/Short Term Debt | 11.322 | 7.437 | 4.932 | 0 | 0 |
Other Current Liabilities, Total | 17.547 | 15.129 | 17.115 | 17.022 | 9.479 |
Total Liabilities | 124.594 | 109.304 | 110.122 | 80.705 | 111.321 |
Total Long Term Debt | 4.4 | 2.161 | 1.645 | 3.18 | 0.885 |
Long Term Debt | 0.003 | 0.013 | 0.062 | 0.379 | 0.885 |
Minority Interest | 1.203 | 1.538 | 1.482 | 0.686 | 0.271 |
Other Liabilities, Total | 4.821 | 4.599 | 4.943 | 4.56 | 6.414 |
Total Equity | 601.076 | 535.81 | 471.395 | 412.968 | 359.883 |
Common Stock | 31.078 | 29.742 | 28.524 | 27.815 | 27.009 |
Additional Paid-In Capital | 1.46 | 1.46 | 1.46 | 1.46 | 1.46 |
Retained Earnings (Accumulated Deficit) | 579.087 | 512.934 | 449.164 | 388.955 | 336.687 |
Treasury Stock - Common | -5.264 | -5.264 | -5.264 | -5.264 | -5.264 |
Other Equity, Total | -5.285 | -3.062 | -2.489 | 0.002 | -0.009 |
Total Liabilities & Shareholders’ Equity | 725.67 | 645.114 | 581.517 | 493.673 | 471.204 |
Total Common Shares Outstanding | 317.765 | 317.804 | 317.832 | 317.849 | 308.666 |
Current Port. of LT Debt/Capital Leases | 16.963 | 6.846 | 7.316 | 7.351 | 47.71 |
Capital Lease Obligations | 4.397 | 2.148 | 1.583 | 2.801 | 0 |
Deferred Income Tax | 19.742 | 21.699 | 17.367 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 313.211 | 307.033 | 293.711 | ||
Efectivo e inversiones a corto plazo | 84.1 | 79.812 | 73.408 | ||
Efectivo y Equivalentes | 66.411 | 76.609 | 70.254 | ||
Inversiones a corto plazo | 17.689 | 3.203 | 3.154 | ||
Total deudores, neto | 114.111 | 120.893 | 112.852 | ||
Accounts Receivable - Trade, Net | 114.111 | 120.893 | 112.852 | ||
Total Inventory | 115 | 106.328 | 107.451 | ||
Total Assets | 725.67 | 677.36 | 645.114 | ||
Property/Plant/Equipment, Total - Net | 205.804 | 165.004 | 139.628 | ||
Intangibles, Net | 178.687 | 182.421 | 182.761 | ||
Long Term Investments | 6.682 | 2.65 | 2.54 | ||
Other Long Term Assets, Total | 21.286 | 20.252 | 26.474 | ||
Total Current Liabilities | 94.428 | 70.558 | 79.307 | ||
Accounts Payable | 36.594 | 37.925 | |||
Notes Payable/Short Term Debt | 11.322 | 0 | 7.437 | ||
Current Port. of LT Debt/Capital Leases | 16.963 | 6.785 | 6.846 | ||
Other Current Liabilities, Total | 17.547 | 11.218 | 15.129 | ||
Total Liabilities | 124.594 | 97.999 | 109.304 | ||
Total Long Term Debt | 4.4 | 2.561 | 2.161 | ||
Long Term Debt | 0.003 | 0.648 | 0.013 | ||
Capital Lease Obligations | 4.397 | 1.913 | 2.148 | ||
Minority Interest | 1.203 | 1.686 | 1.538 | ||
Other Liabilities, Total | 4.821 | 3.58 | 4.599 | ||
Total Equity | 601.076 | 579.361 | 535.81 | ||
Common Stock | 31.078 | 31.078 | 29.742 | ||
Additional Paid-In Capital | 1.46 | 1.46 | 1.46 | ||
Retained Earnings (Accumulated Deficit) | 579.087 | 553 | 512.934 | ||
Treasury Stock - Common | -5.264 | -5.264 | -5.264 | ||
Other Equity, Total | -5.285 | -0.913 | -3.062 | ||
Total Liabilities & Shareholders’ Equity | 725.67 | 677.36 | 645.114 | ||
Total Common Shares Outstanding | 317.765 | 317.765 | 306.034 | ||
Accrued Expenses | 12.002 | 11.97 | |||
Deferred Income Tax | 19.742 | 19.614 | 21.699 | ||
Payable/Accrued | 52.555 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | 89.502 | 83.213 | 73.376 | 64.026 | 51.8 |
Efectivo de actividades de explotación | 106.788 | 79.645 | 78.489 | 67.585 | 59.336 |
Efectivo de actividades de explotación | 19.271 | 16.235 | 14.826 | 12.679 | 10.254 |
Partidas no monetarias | 16.411 | 16.55 | 25.779 | 21.447 | 13.796 |
Cash Taxes Paid | 7.131 | 9.224 | 5.69 | 5.494 | 4.949 |
Intereses pagados en efectivo | 0.263 | 0.216 | 0.266 | 0.051 | 0.256 |
Cambios en el capital circulante | -18.396 | -36.353 | -35.492 | -30.567 | -16.514 |
Efectivo de actividades de inversión | -92.172 | -83.485 | -25.782 | -34.034 | -19.551 |
Gastos de capital | -80.948 | -59.417 | -25.723 | -21.404 | -19.514 |
Otras partidas de flujo de caja de inversión, total | -11.224 | -24.068 | -0.059 | -12.63 | -0.037 |
Efectivo procedente de actividades de financiación | -18.459 | -17.116 | -14.35 | -56.736 | -7.016 |
Elementos de flujo de caja de financiación | -0.312 | -1.947 | 0.458 | 0.358 | 3.18 |
Total Cash Dividends Paid | -18.147 | -13.719 | -12.235 | -10.338 | -7.547 |
Emisión (retiro) de acciones, neto | 0 | -0.092 | -2.834 | -1.58 | |
Emisión (amortización) de deuda, neta | 0 | -1.45 | -2.481 | -43.922 | -1.069 |
Variación neta de la tesorería | -3.843 | -20.956 | 38.357 | -23.185 | 32.769 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 89.502 | 53.055 | 83.213 | ||
Cash From Operating Activities | 106.788 | 61.219 | 79.645 | ||
Cash From Operating Activities | 19.271 | 9.095 | 16.235 | ||
Non-Cash Items | 16.411 | 10.583 | 16.55 | ||
Cash Taxes Paid | 7.131 | 3.474 | 9.224 | ||
Cash Interest Paid | 0.263 | 0.089 | 0.216 | ||
Changes in Working Capital | -18.396 | -11.514 | -36.353 | ||
Cash From Investing Activities | -92.172 | -36.157 | -83.485 | ||
Capital Expenditures | -80.948 | -36.187 | -59.417 | ||
Other Investing Cash Flow Items, Total | -11.224 | 0.03 | -24.068 | ||
Cash From Financing Activities | -18.459 | -18.707 | -17.116 | ||
Financing Cash Flow Items | -0.312 | -1.15 | -1.947 | ||
Total Cash Dividends Paid | -18.147 | -18.147 | -13.719 | ||
Issuance (Retirement) of Debt, Net | 0 | 0.59 | -1.45 | ||
Net Change in Cash | -3.843 | 6.355 | -20.956 | ||
Issuance (Retirement) of Stock, Net | 0 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Indumenta Pueri, S.L. | Corporation | 4.8308 | 15539141 | -641 | 2022-12-31 | LOW |
Santander Asset Management | Investment Advisor | 2.9656 | 9539158 | 7517636 | 2023-03-31 | MED |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.8846 | 9278813 | -53836 | 2022-11-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6881 | 8646561 | 46525 | 2023-04-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.604 | 5159379 | 584 | 2023-04-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4205 | 4569187 | 32423 | 2023-04-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 1.1922 | 3834987 | 0 | 2023-04-30 | LOW |
Zavala Ortiz de la Torre (Iñigo) | Individual Investor | 0.744 | 2393028 | 225192 | 2021-12-31 | |
Argenta Asset Management SA | Investment Advisor | 0.6261 | 2013895 | 0 | 2023-03-31 | LOW |
Ucar Angulo (Mariano) | Individual Investor | 0.4638 | 1491758 | 236695 | 2021-12-31 | |
Serafin Asset Management AG | Investment Advisor | 0.3751 | 1206605 | 1206605 | 2022-07-31 | MED |
Nuveen LLC | Pension Fund | 0.3647 | 1173118 | 0 | 2023-03-31 | LOW |
Praude Asset Management Ltd. | Investment Advisor | 0.3602 | 1158797 | 0 | 2023-04-30 | MED |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.3451 | 1110168 | 717 | 2023-04-30 | LOW |
Alcocer Torra (Carlos) | Individual Investor | 0.3188 | 1025583 | 90980 | 2021-12-31 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2887 | 928732 | -725 | 2023-04-30 | LOW |
Fernandez de Valderrama Iribarnegaray (Gonzalo) | Individual Investor | 0.2802 | 901270 | 102593 | 2021-12-31 | |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.2744 | 882508 | 5334 | 2023-04-30 | LOW |
Value Square N.V. | Investment Advisor | 0.2212 | 711522 | 73788 | 2023-02-28 | LOW |
Magallanes Value Investors, S.A., SGIIC | Investment Advisor | 0.1896 | 609722 | 0 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Faes Farma Company profile
Sobre FAES Farma SA
FAES FARMA SOCIEDAD ANONIMA es una compañía con sede en España dedicada a la industria farmacéutica. La Compañía se especializa en la investigación, producción, distribución y venta de medicamentos genéricos y con receta, medicamentos de venta libre, suplementos alimenticios y tratamientos de cuidado personal, así como materias primas para uso farmacéutico. Las líneas de investigación de la Compañía se centran principalmente en el desarrollo de nuevos fármacos para el tratamiento de la alergia, la insuficiencia venosa y el síndrome de intestino irritable, entre otros. Además, proporciona productos de nutrición animal. La Compañía opera en España, Portugal, Chile y México, entre otros países. Controla una serie de filiales, como Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA y Biotecnet I MAS D SA.
El precio actual de la acción Faes Farma, S.A. en tiempo real es 3.35 EUR. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Pentair, iShares Trust - iShares MBS ETF, Sabana Reit, Greenwich LifeSciences, Inc., Enovix Corporation y Ormat Technologies, Inc.. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Pharmaceuticals (NEC) |
Parque Empresarial Cristalia. Calle Vía de los Poblados 3, Edificio 2, 2º Izquierda
MADRID
MADRID 28033
ES
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com